Analysis of DRG grouping effect and influential factors of hospitalization cost of diabetic patients

NIE Xiaojing; FU Haofei; BAI Hehe; LI Yaping; WANG Jinping

doi:10.6039/j.issn.1001-0408.2023.24.11

您当前的位置：

首页 >

文章列表页 >

Analysis of DRG grouping effect and influential factors of hospitalization cost of diabetic patients

更新时间：2023-12-22

- Analysis of DRG grouping effect and influential factors of hospitalization cost of diabetic patients
- ZHONGGUO YAOFANG Vol. 34, Issue 24, Pages: 3020-3024(2023)
- 作者机构：
  
  1.西安市中心医院药剂科，西安　710003
  2.西安市中心医院质控科，西安　710003
- 作者简介：
- 基金信息：
- DOI：10.6039/j.issn.1001-0408.2023.24.11
  CLC： R95
- Published：30 December 2023，
  
  Received：21 June 2023，
  
  Revised：20 November 2023，
扫描看全文
聂晓静,付豪斐,白荷荷等.糖尿病患者DRG分组效果及住院费用影响因素分析 ^Δ[J].中国药房,2023,34(24):3020-3024.

NIE Xiaojing,FU Haofei,BAI Hehe,et al.Analysis of DRG grouping effect and influential factors of hospitalization cost of diabetic patients[J].ZHONGGUO YAOFANG,2023,34(24):3020-3024.
聂晓静,付豪斐,白荷荷等.糖尿病患者DRG分组效果及住院费用影响因素分析 ^Δ[J].中国药房,2023,34(24):3020-3024. DOI： 10.6039/j.issn.1001-0408.2023.24.11.

NIE Xiaojing,FU Haofei,BAI Hehe,et al.Analysis of DRG grouping effect and influential factors of hospitalization cost of diabetic patients[J].ZHONGGUO YAOFANG,2023,34(24):3020-3024. DOI： 10.6039/j.issn.1001-0408.2023.24.11.

摘要

目的

探讨糖尿病疾病诊断相关分组（DRG）的分组效果及住院费用控制的影响因素，为完善DRG付费体系、降低医疗费用、提高医保基金使用效能提供依据。

方法

回顾性分析2021年1月1日至2023年6月30日西安市某三级甲等医院住院治疗的4 368例糖尿病患者的病案信息，汇总其DRG分组情况，采用单因素方差分析和Bonferroni多重比较分析不同DRG分组患者的住院费用，采用变异系数（CV）评价组内异质性，采用单因素线性回归分析和多元线性回归分析探讨影响住院费用的因素。结果与

结论

4个DRG组患者住院费用的CV值均小于0.8，分组结果较好且组内一致性较好；4组患者住院费用比较差异有统计学意义，且国家医疗保障局DRG1.1版FW11组患者的住院费用显著高于其他3组（

＜0.05）。住院天数、药品费用、其他诊断数量、检验费用和付款方式对糖尿病患者的住院费用有显著正向影响；是否有药师干预对患者的住院费用有显著负向影响。在DRG支付方式下，医疗机构可考虑多学科联动，纳入包括药师干预在内的多种管理和服务工具，制定精细化管理措施，从而降低患者家庭和社会的经济负担。

Abstract

OBJECTIVE

To explore the grouping efficacy of diagnosis related group （DRG） and the influential factors of hospitalization cost in diabetes cases， and to provide theoretical support for improving DRG payment system， reducing medical cost and enhancing the efficiency of medical insurance funds.

METHODS

The information of 4 368 diabetic patients who were hospitalized in a 3A hospital in Xi’an from January 1， 2021 to June 30， 2023 was retrospectively analyzed， and DRG grouping of them was summarized； the hospitalization costs of patients in different DRG groups were analyzed by using one way ANOVA and Bonferroni multiple comparison. Coefficient of variation （CV） was used for evaluation within the group， and the influential factors of hospitalization costs were analyzed by one-way linear regression analysis and multi-factor linear regression analysis.

RESULTS

CONCLUSIONS

The CV values of the four DRG groups were all lower than 0.8， indicating good grouping results and good consistency within the group； the difference of hospitalization cost among the four groups was statistically significant （

＜0.05）， and the hospitalization cost of China Healthcare Security-DRG version 1.1 FW11 group was significantly higher than those of other three groups （

＜0.05）. Length of stay， drug cost， the number of other diagnoses， test cost and payment method have significant positive effects on the hospitalization cost of diabetic patients. Whether there is pharmacist intervention has a significant negative influence on the hospitalization cost of patients. Under the DRG payment method， medical institutions can consider multidisciplinary linkage and incorporate a variety of management and service tools， including pharmacist’s intervention， to develop refined management measures， to reduce the economic burden of patients’ families and society.

关键词

疾病诊断相关分组糖尿病住院费用影响因素

Keywords

diabeteshospitalization costinfluential factors

references

International Diabetes Federation. IDF diabetes atlas 2021，10th edition[EB/OL].（2021-12-06）[2023-06-20]. https：//diabetesatlas.org/idfawp/resource-files/2021/07/IDF_ Atlas_10th_Edition_2021.pdfhttps://diabetesatlas.org/idfawp/resource-files/2021/07/IDF_Atlas_10th_Edition_2021.pdf.

李敏强，彭颖，程明，等. 国外DRGs定价与支付体系对我国医保支付方式改革启示[J]. 中国医院，2021，25（1）：58-61.

LI M Q，PENG Y，CHENG M，et al. The reference significance of foreign DRGs implementation strategy to the reform of medical insurance payment in China[J]. Chin Hosp，2021，25（1）：58-61.

HUNTER W G，HESSON A，DAVIS J K，et al. Patient-physician discussions about costs：definitions and impact on cost conversation incidence estimates[J]. BMC Health Serv Res，2016，16：108.

伍达锋. 基于DRG分组下的子宫平滑肌瘤住院费用影响因素分析[J]. 中国病案，2022，23（2）：61-64.

WU D F. Analysis of influencing factors of hospitalization expenses for uterine leiomyoma based on DRG grouping[J]. Chin Med Rec，2022，23（2）：61-64.

申鑫，韩春艳，甘勇，等. 基于DRG的医疗服务绩效评价体系构建研究[J]. 中国卫生政策研究，2020，13（3）：77-82.

SHEN X，HAN C Y，GAN Y，et al. Research on construction of the performance evaluation system of medical services based on DRG[J]. Chin J Health Policy，2020，13（3）：77-82.

李文瑾，续晓方，田立启，等. 基于DRG的乳腺癌手术患者住院费用及影响因素分析[J]. 卫生经济研究，2021，38（6）：76-79.

LI W J，XU X F，TIAN L Q，et al. Analysis on hospitalization expenses and its influencing factors of breast cancer patients based on DRG[J]. Health Econ Res，2021，38（6）：76-79.

李洋，毛静馥，黄卫东，等. 全民医保视角下糖尿病患者住院费用结构及影响因素分析[J]. 中国卫生经济，2019，38（10）：69-71.

LI Y，MAO J F，HUANG W D，et al. Analysis on inpatient cost structure and influencing factors of diabetes patients from the perspective of universal medical insurance[J]. Chin Health Econ，2019，38（10）：69-71.

杜慧杰，郑二维. 糖尿病患者住院费用影响因素分析[J]. 中国病案，2022，23（5）：45-48.

DU H J，ZHENG E W. Analysis on the influencing factors of hospitalization expenses of diabetic patients[J]. Chin Med Rec，2022，23（5）：45-48.

员浩雅，徐福强，张军，等. 四种癌症患者长期治疗费用及影响因素分析：以济南市某三甲医院为例[J]. 中国卫生事业管理，2019，36（10）：740-742，772.

YUAN H Y，XU F Q，ZHANG J，et al．Analysis on long-term treatment expenses of four kinds of cancers and its influencing factors： take a third-class hospital in Jinan as a example[J]. Chin Health Serv Manag，2019，36（10）：740-742，772.

陆伟. 不同医保类别糖尿病患者住院费用分析[J]. 医院管理论坛，2012，29（12）：25-27，33.

LU W. Analysis of hospitalization expense for diabetic patients in different medical insurance status[J]. Hosp Manag Forum，2012，29（12）：25-27，33.

薛飞，项程，胡书琛，等. 新医改后糖尿病患者住院费用分析[J]. 中国社会医学杂志，2022，39（2）：218-221.

XUE F，XIANG C，HU S C，et al. Analysis of diabetes hospitalization cost after the new medical reform[J]. Chin J Soc Med，2022，39（2）：218-221.

朱麒钱，俞利红，缪凡，等. 糖尿病患者住院医疗费用的影响因素分析[J]. 中国糖尿病杂志，2007，15（5）：307-309.

ZHU Q Q，YU L H，MIAO F，et al. Analysis of the factors influencing cost in diabetes inpatients in Shaoxing Renmin Hospital[J]. Chin J Diabetes，2007，15（5）：307-309.

李秀梅，刘理，胡海源，等. DRG支付下脑卒中患者住院费用控制研究[J]. 卫生经济研究，2022，39（1）：44-47.

LI X M，LIU L，HU H Y，et al. Research on the control of hospitalization expenses of stroke patients in the context of DRG payment[J]. Health Econ Res，2022，39（1）：44-47.

杨朗，魏俊吉，银锐，等. DRG支付方式下垂体手术患者住院费用影响因素研究[J]. 协和医学杂志，2023，14（1）：148-152.

YANG L，WEI J J，YIN R，et al. Influencing factors of hospital costs for pituitary tumor under DRG payment[J]. Med J Peking Union Med Coll Hosp，2023，14（1）：148-152.

聂晓静，白荷荷，张利红，等. 药物重整对老年2型糖尿病患者慢病管理的效果评价[J]. 药物流行病学杂志，2020，29（9）：623-628.

NIE X J，BAI H H，ZHANG L H，et al. Effect evaluation of medication reconciliation in chronic disease management for elderly patients with type 2 diabetes[J]. Chin J Pharmacoepidemiol，2020，29（9）：623-628.

李黎，张丹，周楠，等. 在疾病诊断相关分组支付模式下临床药师对周围性面神经麻痹患者成本管控的效果分析[J]. 中国临床药学杂志，2022，31（6）：407-410.

LI L，ZHANG D，ZHOU N，et al. Analysis of the effect of clinical pharmacists on the cost control of patients with peripheral facial paralysis under diagnosis related groups payment model[J]. Chin J Clin Pharm，2022，31（6）：407-410.

The Joint Commission.Hospital：2023 national patient safety goals[J/OL].[2023-07-01].http：//www.jointcommission.org/standards/national-patient-safety-goals/hospital-national-patient-safety-goalshttp://www.jointcommission.org/standards/national-patient-safety-goals/hospital-national-patient-safety-goals.

KILCUP M，SCHULTZ D，CARLSON J，et al. Postdischarge pharmacist medication reconciliation：impact on readmission rates and financial savings[J]. J Am Pharm Assoc，2013，53（1）：78-84.

MCNAB D，BOWIE P，ROSS A，et al. Systematic review and meta-analysis of the effectiveness of pharmacist-led medication reconciliation in the community after hospital discharge[J]. BMJ Qual Saf，2018，27（4）：308-320.

LIN H W，LIN C H，CHANG C K，et al. Economic outcomes of pharmacist-physician medication therapy ma-nagement for polypharmacy elderly：a prospective，rando-mized，controlled trial[J]. J Formos Med Assoc，2018，117（3）：235-243.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Analysis of influential factors for purchasing quantity changes in the procurement varieties of the first batch of drug centralized procurement

The characteristics and influencing factors of medicine cost for orthopedic surgery patients in hospitals of Shanxi province

Analysis of the burden of polypharmacy and its influencing factors among elderly tuberculosis patients in Guizhou province

Analysis of influential factors for the failure of tigecycline in the treatment of multidrug-resistant Acinetobacter baumannii pneumonia

我国省级基本药物增补情况与影响因素分析

Related Author

LIU Yuxin

WEN Xiaotong

DUAN Fengran

WANG Yue

YANG Ying

MAO Zongfu

LI Weipeng

SHANG Nan

Related Institution

Dong Fureng Institution of Economic and Social Development， Wuhan University

Global Health Institute， Wuhan University

School of Public Health， Wuhan University

School of Nursing， Tongji Medical College of Huazhong University of Science and Technology

School of Pharmacy， Shanxi Medical University

Address：8/F,129 Daping Main Street,Yuzhong District,Chongqing 400042,P.R.China
Technical support is provided by Beijing Founder Electronics co., LTD 渝ICP备15012710号公网安备50010302001817
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰